PROPHYLIX PHARMA HOLDING AS

Facts

Source: Firmafakta, with business data from public registers.

organisasjonsnummer:

920056245

navn:

PROPHYLIX PHARMA HOLDING AS

organisasjonsform:

kode:

AS

beskrivelse:

Aksjeselskap

naeringskode1:

kode:

21.200

beskrivelse:

Produksjon av farmasøytiske preparater

antallAnsatte:

not reported by source

hjemmeside:

not reported by source

epostadresse:

not reported by source

telefon:

not reported by source

forretningsadresse:

adresse:

Forskningsparken, Sykehusvegen 23

poststed:

TROMSØ

postnummer:

9019

kommune:

TROMSØ

stiftelsesdato:

2017-11-27

registreringsdatoenhetsregisteret:

2017-12-11

aktivitet:

Å investere i aksjer og i andre selskaper og alt som står i, forbindelse med dette.

vedtektsfestetFormaal:

Å investere i aksjer og i andre selskaper og alt som står i, forbindelse med dette.

View the address in Geonorge

Board and other roles

Source: Firmafakta. Also see the separate Brønnøysund lookup under related lookups.

Regnskapsfører

• Regnskapsfører: FETT ØKONOMI AS

Styre

• Styremedlem: Sveinung Hole
• Styrets leder: Karl Johan Jakola

Owners

Source: Firmafakta shareholder dataset.

1. TROND MOHN FORSKNINGSSTIFTELSE – 15.51 % (94463 shares, share class: H-aksjer)
2. NORINNOVA INVEST AS – 10.82 % (65894 shares, share class: B-aksjer)
3. NORINNOVA INVEST AS – 9.09 % (55388 shares, share class: H-aksjer)
4. SARSIA SEED AS – 6.4 % (38957 shares, share class: H-aksjer)
5. NORINNOVA INVEST AS – 5.81 % (35394 shares, share class: E-aksjer)
6. SARSIA SEED AS – 5.81 % (35394 shares, share class: E-aksjer)
7. NORINNOVA INVEST AS – 5.72 % (34871 shares, share class: F-aksjer)
8. NORINNOVA AS – 5.47 % (33334 shares, share class: A-aksjer)
9. UNIVERSITETSSYKEHUSET NORD-NORGE HF – 4.93 % (30001 shares, share class: A-aksjer)
10. SARSIA SEED AS – 3.61 % (21965 shares, share class: B-aksjer)
11. SARSIA SEED AS – 3.27 % (19926 shares, share class: F-aksjer)
12. KRAKR AS – 2.04 % (12436 shares, share class: H-aksjer)
13. BJØRN RAGNAR SKOGEN – 1.96 % (11933 shares, share class: A-aksjer)
14. NORINNOVA AS – 1.93 % (11742 shares, share class: C-aksjer)
15. METTE KJÆR – 1.8 % (10991 shares, share class: B-aksjer)
16. BO JESPER HANSEN – 1.8 % (10982 shares, share class: B-aksjer)
17. METTE KJÆR – 1.76 % (10733 shares, share class: A-aksjer)
18. NORINNOVA AS – 1.51 % (9184 shares, share class: D-aksjer)
19. ANNE HUSEBEKK – 1.37 % (8333 shares, share class: A-aksjer)
20. JENS KJELDSEN-KRAGH – 1.08 % (6567 shares, share class: A-aksjer)
21. CAERUS CAPITAL AS – 0.99 % (6000 shares, share class: H-aksjer)
22. UNIVERSITETSSYKEHUSET NORD-NORGE HF – 0.81 % (4926 shares, share class: D-aksjer)
23. ROLF JORDE – 0.72 % (4396 shares, share class: B-aksjer)
24. ANNE KELLER – 0.68 % (4166 shares, share class: A-aksjer)
25. ROLF JORDE – 0.57 % (3495 shares, share class: H-aksjer)
26. METTE KJÆR – 0.56 % (3387 shares, share class: H-aksjer)
27. INVEN2 AS – 0.55 % (3356 shares, share class: H-aksjer)
28. INVEN2 AS – 0.55 % (3333 shares, share class: A-aksjer)
29. SØREN WEISS DAHL – 0.53 % (3200 shares, share class: A-aksjer)
30. METTE KJÆR – 0.43 % (2615 shares, share class: E-aksjer)
31. SØREN WEISS DAHL – 0.33 % (2000 shares, share class: G-aksjer)
32. ROLF JORDE – 0.33 % (1993 shares, share class: F-aksjer)
33. MAGNUS SEPPOLA – 0.26 % (1600 shares, share class: A-aksjer)
34. METTE KJÆR – 0.19 % (1127 shares, share class: G-aksjer)
35. ANNE HUSEBEKK – 0.16 % (1000 shares, share class: F-aksjer)
36. CAERUS CAPITAL AS – 0.16 % (1000 shares, share class: G-aksjer)
37. JONAS LUNDAHL – 0.16 % (1000 shares, share class: F-aksjer)
38. MAGNUS SEPPOLA – 0.14 % (846 shares, share class: H-aksjer)
39. PHARMAPATENT AS – 0.11 % (666 shares, share class: H-aksjer)
40. JENS KJELDSEN-KRAGH – 0.09 % (536 shares, share class: H-aksjer)

Fetch a longer owner list

Company holdings

• PROPHYLIX AS – 100.00 %

Grants and support

Sources provided through Firmafakta: Innovation Norway, the EU, the Research Council of Norway and SkatteFUNN.

Innovasjon Norge (0)

No registered grants.

EU-tildelinger (0)

No registered grants.

Forskningsrådet (0)

No registered grants.

SkatteFUNN (0)

No registered grants.

Open positions

count:

0

stillinger:

No results.

Related lookups

• Doffin notices where PROPHYLIX PHARMA HOLDING AS is the buyer
• Search broadly for PROPHYLIX PHARMA HOLDING AS in Doffin
• Open positions related to PROPHYLIX PHARMA HOLDING AS
• Latest financial statement
• Patents and trademarks
• Official entity information from the Brønnøysund Register Centre
• Official roles from the Brønnøysund Register Centre
• Corporate group structure from the Brønnøysund Register Centre